Cergutuzumab amunaleukin
Product Specifications
CAS Number
1509916-03-3
Target
Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.997
Bioactivity
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with immunostimulatory and anti-tumor activities for the study of solid cancers.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0748605 3x 1.0 µg
FAM150B sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 